Stryker was hit by a cyberattack this week that knocked out its internal systems worldwide and caused delays to order processing and manufacturing. An Iran-linked group has claimed responsibility for the attack, but the full impact remains unclear.
During Reuters’ MedTech conference, medical device leaders shared three common misconceptions they believe hospital leaders often have about AI. They stressed that AI in healthcare is meant to augment — not replace — clinicians.
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.
Don't mistake Stryker's latest $500 million deal in the spine market as a simple tuck-in acquisition, says one analyst while another says it could help Stryker give Medtronic a run for its money.
The acquisition price for the Israeli company was $110 million in upfront cash payments with the potential for an additional $110 million upon meeting certain commercial milestones.
Analysts say that Stryker's purchase of a small but fast-growing public company in the complex spine market should help its own struggling spine business.
Stryker is shelling out top dollar to buy Novadaq, a maker of fluorescence imaging technologies that allows surgeons to see blood flow in vessels during surgery in real time.
What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.
Orthopedics heavyweight Stryker is leveraging Microsoft's Microsoft HoloLens holographic technology to reimagine the operating room and bring efficiencies to hospitals.
The shift from volume to value is no where more apparent than in the orthopedics specialty where vendors that once obsessed over titanium and steel are now focusing on services to manage the bundled payment era.
As the buzz around robotics grows, J&J 's DePuy Synthes is touting the clinical and economic evidence tied to its non-robotic knee platform to help hospitals navigate the bundled payments era, but will that sway them?
Stryker is launching its Triathlon total knee on its Mako robotic system, reportedly priced at $1 million, at a time of bundled payments and cost consciousness in joint replacement procedures.
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
Zimmer Biomet just acquired a telerehab startup, RespondWell, to play in a different part of the bundle as it relates to the Comprehensive Care for Joint Replacement program for hip and knee replacements. Stryker is not interested in such technology.
Smart medtech companies are realizing that they have to be partners to hospitals and not simply vendors selling widgets.
The SurgiCount product has been available for years, but Stryker is now standing by its product in a unique and perhaps rarely confident way. The device company is calling it the SurgiCount Promise.
Washington-based Physio-Control will be integrated into Stryker’s emergency medical systems portfolio.
Neurotechnology, mobility and robotics are the main focuses for Stryker moving forward.